Navigation Links
MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International, Inc., MEDA Pharmaceuticals Inc., and Aveva Drug Delivery Systems, Inc.
Date:1/18/2011

WARREN, N.J., Jan. 18, 2011 /PRNewswire/ -- MonoSol Rx, LLC ("MonoSol Rx"), the developer of PharmFilm® drug delivery technology, filed an amended patent infringement and false marking lawsuit today against BioDelivery Sciences International, Inc. (NASDAQ: BDSI; "BDSI"), MEDA Pharmaceuticals Inc. ("MEDA"), and Aveva Drug Delivery Systems, Inc. ("Aveva") in the United States District Court for the District of New Jersey.

MonoSol Rx's complaint asserts that BDSI, MEDA, and Aveva's manufacture, marketing, and sale of the Onsolis™ film products infringe MonoSol Rx's United States Patent No. 7,824,588 related to methods of making drug-containing films.  As one of the leaders in the development and commercialization of film pharmaceutical and over-the-counter drug products, MonoSol Rx has an extensive technology patent portfolio.

MonoSol Rx filed its patent infringement claim against these defendants initially in November, 2010.  Today's amended complaint adds an additional false marking claim with respect to U.S. Patent No. 5,800,832.

MonoSol Rx is represented in the action by Howrey LLP.

About MonoSol Rx MonoSol Rx is a specialty pharmaceutical company leveraging its proprietary PharmFilm® technology to deliver drugs in films. PharmFilm® is designed to benefit patients by improving the convenience, efficacy, and compliance of new and currently marketed drugs. The Company's leadership in film drug delivery is supported by strong intellectual property, a portfolio of commercialized prescription and over-the-counter (OTC) drug products, a pipeline of prescription formulations based on PharmFilm® technology, and two recent FDA approvals - Zuplenz®, the first approved prescription oral soluble film for the prevention of chemotherapy-induced, radiotherapy-induced, and postoperative nausea and vomiting, and Suboxone®  sublingual film, the first sublingual film product for the treatment of opioid dependence.  

MonoSol Rx's commercialization strategy for all PharmFilm® products is to partner with the innovator or other specialty pharma companies that can sell-in and manage product sales and marketing.  PharmFilm® is also a tool to help sales and marketing partners differentiate in competitive markets while offering unique advantages over drugs dosed by traditional tablets, capsules and orally disintegrating tablets (ODTs).For existing and future partners, PharmFilm® formulations can also represent revenue-life cycle extensions for products with patent lives that have expired or are approaching expiration.
For press releases and other company information visit www.monosolrx.com Contacts:MonoSol RxKeith Kendall, Executive Vice President(732) 564-5000The Ruth Group
(on behalf of MonoSol Rx)Jason Rando (media)Tel: +1 (646) 536-7025jrando@theruthgroup.com  Sara Pellegrino (investors)Tel: +1 (646) 536-7002spellegrino@theruthgroup.com  
'/>"/>

SOURCE MonoSol Rx, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MonoSol Rx Issued Strategic U.S. Patent Governing the Manufacturing of Pharmaceutical Films
2. MonoSol Rx Completes Thin Film Escitalopram Oxalate Pilot Product Development
3. MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study
4. ThermoGenesis Corp. Files Shelf Registration Statement on Form S-3
5. HeartWare Files PMA Application for FDA Approval of the HeartWare® Ventricular Assist System for a Bridge-to-Transplant Indication
6. Cannabis Science Files Preliminary 14c Information Statement, the Action is to Create a New Class of Common Stock and Issue Dividend
7. COPAN Files New Patents Following the Development of High Nucleic Acid Yield Flocked Swabs
8. Cell Therapeutics Files Appeal on FDA Decision on New Drug Application (NDA) for Pixantrone to Treat Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma
9. AcelRx Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
10. ERT Files Shelf Registration Statement
11. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... and PUNE, India , January 16, ... report published by Allied Market Research, titled, "Sterilization Technologies ... and Industry Forecast, 2014-2022," the global sterilization technologies market ... $5,768 million in 2015, growing at a CAGR of ... sterilization segment dominated the market in 2015, with more ...
(Date:1/16/2017)... N.J. , Jan. 16, 2017   Linde Gas ... all of the assets and business of The Service Center ... equipment repair services to healthcare providers in the Midwest and ... Broadview, Illinois , The Service Center also ... Greenville, South Carolina . Its primary services ...
(Date:1/16/2017)... 2017  Rigel Pharmaceuticals (Nasdaq: RIGL ) ... 16, 2017 the Compensation Committee of Rigel,s Board of ... purchase an aggregate of 214,000 shares of common stock ... to the Rigel Pharmaceuticals, Inc. Inducement Plan, as amended, ... into employment with Rigel, in accordance with NASDAQ Listing ...
Breaking Medicine Technology:
(Date:1/16/2017)... ... January 16, 2017 , ... Atlanta-based incentive company Incentive ... the wheelchair accessibility industry, BraunAbility . Incentive Solutions will provide BraunAbility a ... vehicles. With this new incentive plan, BraunAbility plans to continue their tradition of ...
(Date:1/16/2017)... ... January 16, 2017 , ... In 1985, the ... high-level training standards to an international multidisciplinary group of healthcare treatment providers and ... way to further its mission at the grassroots level, iaedp launched MemberSHARE, an ...
(Date:1/16/2017)... ... , ... NexTec Group has been selected as a member of the Bob ... in the field of midmarket financial software. , Members of the VAR Stars were ... not based on revenue and those firms chosen represent a wide range of size ...
(Date:1/15/2017)... ... 15, 2017 , ... Accreditation Commission for Health Care (ACHC) ... care services. Albertsons Companies is the largest national food and drug chain ... , Accreditation by ACHC reflects Albertsons Companies’ dedication and commitment to meeting national ...
(Date:1/15/2017)... ... January 15, 2017 , ... The Gravity Vault Indoor ... Radnor, Pennsylvania. As construction wraps up on the 14,000+ square foot climbing gym, the ... sixth location, including three in New Jersey and two in New York. With this ...
Breaking Medicine News(10 mins):